Authors: Melissa Healy\u00a0 \u00a06 hrs ago<\/p>\n\n\n\n
COVID-19 patients in Wuhan were among the pandemic\u2019s first victims, and a comprehensive new study finds that a year after shaking the coronavirus, survivors were more likely than their uninfected peers to suffer from mobility problems, pain or discomfort, anxiety and depression.<\/p>\n\n\n\n
A detailed accounting<\/a> of 1,276 people hospitalized for COVID-19 in the pandemic\u2019s opening months reveals that a full year later, almost half continued to report at least one lingering health problem that is now considered a symptom of \u201clong COVID.\u201d<\/a><\/p>\n\n\n\n One out of five said they had continued fatigue and\/or muscle weakness, and 17% said they were still experiencing sleep difficulties. Just over one in four said they were suffering anxiety or depression in the wake of their bout with the SARS-CoV-2 virus.<\/p>\n\n\n\n For the growing number of patients who identify themselves as COVID \u201clong haulers,\u201d the new accounting offers cause for optimism \u2014 and concern. The period from six to 12 months after infection brought improvement for many. But most patients struggling with symptoms at the six-month mark were not yet well six months later.<\/p>\n\n\n\n The findings, catalogued by a team of Chinese researchers, were published late Thursday in the medical journal Lancet.<\/p>\n\n\n\n \u201cThis is not good news,\u201d said David Putrino<\/a>, a rehabilitation specialist who works with COVID long haulers at Mount Sinai Hospital in New York. \u201cIf you run the numbers here, about one-third of the group that had persistent symptoms are getting better after 12 months, while two-thirds are not.\u201d<\/p>\n\n\n\n Putrino also called the findings a \u201cwake-up call\u201d to public health officials that even when the pandemic is over \u2014 a distant enough prospect in the midst of a fourth wave of infections \u2014 its downstream consequences will not be.<\/p>\n\n\n\n \u201cWe\u2019re going to need resources for many years to come to deal with these patients,\u201d he said.<\/p>\n\n\n\n There will be a lot of them. More than 87,000 COVID-19 patients are being hospitalized<\/a> each day in the United States, and 2.7 million have receiving hospital care in the past year alone.<\/p>\n\n\n\n The half who contend with persistent symptoms will show up in doctors\u2019 offices with clusters of vague and perplexing complaints including brain fog, heart palpitations, pain and exhaustion. And despite emerging evidence<\/a> that time and specialized treatment can help many to improve, few will have the wherewithal to spend months in intensive rehabilitation for their symptoms, Putrino said.<\/p>\n\n\n\n An editorial<\/a> published alongside the new study noted that only 0.4% of COVID long haulers are receiving rehabilitative treatment for their symptoms.<\/p>\n\n\n\n Even as scientists puzzle over the common biological mechanisms of long COVID’s diverse symptoms, healthcare providers “must acknowledge and validate the toll of the persistent symptoms of long COVID on patients, and health systems need to be prepared to meet individualised, patient-oriented goals, with an appropriately trained workforce,” Lancet’s editors wrote.<\/p>\n\n\n\n The new research also offered some glimmers of hope.<\/p>\n\n\n\n When the study\u2019s COVID-19 patients were examined at six months, 68% said they had at least one of 15 symptoms considered hallmarks of long COVID, which is also known as Post-Acute Sequelae of COVID<\/a>, or PASC. At one year, 49% were still afflicted by at least one of those symptoms.<\/p>\n\n\n\n The proportion of patients with ongoing muscle weakness and fatigue dropped from 52% to 20% during that time. Patients experiencing loss of smell dropped from 11% to 4%, and those afflicted with sleep problems fell from 27% to 17%. The 22% who reported hair loss at six months dwindled to 11% a full year out.<\/p>\n\n\n\n At the same time, the numbers of patients reporting breathing difficulties saw a slight increase, rising from 26% at six months to 30% after a year. Likewise, patients who reported new depression or anxiety increased from 23% to 26% during that period.<\/p>\n\n\n\n